Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lab Sector Vs. CMS Battle Heats Up As Medicare Agency Moves Forward With 2018 Rates

Executive Summary

Test-makers and labs say the agency is missing large swaths of the market in making its "market-based" lab payment calculation, but CMS stands by its data, and finalized 2018 lab fee schedule rates. Could next steps be in Congress, or the courts?

Advertisement

Related Content

US District Court Dismisses Suit Filed By Labs On Test-Pay Rule
CMS Proposes To Cover More Telehealth, And Address Imaging, Lab Pay Matters
Labs File Suit Against US Government In Dx Pay-Rule Case
Lab Industry Says PAMA Reimbursement Rates Not Really Market-Based
Medicare Dx Payment System Will Be Market-Based, More Transparent Under New Law

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT121794

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel